Company / Interest Expense per Share
Compass Therapeutics, Inc. Interest Expense per Share History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
-
FY2022
5-year range
$0.00 / $0.03
FY2018-FY2022
Trend
-100.0%
vs FY2021
Sector context
#41 of 45
Health Care
What the data says
Improved from $0.03 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 45
▼
Key checks
Key Insights
- Compass Therapeutics, Inc.'s interest expense per share has declined for 3 consecutive years.
- In FY2022, interest expense per share decreased 100.0% year-over-year.
- Peak interest expense per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $0.01 | -80.1% |
| FY2020 | $0.03 | -83.9% |
| FY2019 | $0.18 | +27894.2% |
| FY2018 | $0.00 | - |
As of FY2022 · SEC 10-K · Updated Feb 28, 2026